https://www.selleckchem.com/products/bay-293.html
This study demonstrates, for the first time, the bioactivity of C. uvifera leaf as a new source of high biological value compounds (HBVC), which can be of interest to the food and pharmaceutical industries. This study demonstrates, for the first time, the bioactivity of C. uvifera leaf as a new source of high biological value compounds (HBVC), which can be of interest to the food and pharmaceutical industries. The quercetin has potential against the multidrug resistance (MDR) phenotype, but with low bioavailability. The increase in the
Like
Comment
Share
